Investigation of Specific Proteins Related to Different Types of Coronary Atherosclerosis

Heyu Meng1, Jianjun Ruan1, Yanqiu Chen1

  • 1Jilin Provincial Precision Medicine Key Laboratory for Cardiovascular Genetic Diagnosis (Jilin Provincial Engineering Laboratory for Endothelial Function and Genetic Diagnosis of Cardiovascular Disease, Jilin Provincial Molecular Biology Research Center for Precision Medicine of Major Cardiovascular Disease, Jilin Provincial Cardiovascular Research Institute), Department of Cardiology, China-Japan Union Hospital of Jilin University, Changchun, China.

Insights

This study identified six lipid metabolism proteins (ALB, SHBG, APOC2, APOC3, APOC4, SAA4) as potential diagnostic markers for atherosclerosis. These protein changes improve the accuracy of diagnosing coronary heart disease, aiding in timely treatment.

Area of Science:

  • Biochemistry
  • Proteomics
  • Cardiovascular Disease Research

Background:

  • Coronary heart disease (CHD) diagnosis is challenging due to complex genetic and environmental interactions.
  • Atherosclerosis, encompassing stable coronary artery disease (SCAD) and acute myocardial infarction (AMI), requires accurate and timely diagnosis for effective management.
  • Identifying specific protein biomarkers is crucial for differentiating atherosclerosis subtypes and guiding treatment strategies.

Purpose of the Study:

  • To identify specific protein markers for the differential diagnosis of coronary atherosclerosis.
  • To investigate the role of lipid metabolism-associated proteins in atherosclerosis.
  • To validate potential protein biomarkers using parallel reaction monitoring (PRM) and receiver operating characteristic (ROC) analysis.

Main Methods:

  • Tandem mass tag (TMT) mass spectrometry was used to analyze proteins in 30 male patients (45-55 years) with atherosclerosis, excluding those with hypertension or diabetes.
  • Mufuzz analysis identified target proteins, with a focus on those related to lipid metabolism.
  • Parallel reaction monitoring (PRM) and random forest ROC analysis were employed for verification and diagnostic accuracy assessment.

Main Results:

  • 1,147 proteins were identified, with 907 quantifiable via TMT mass spectrometry.
  • Six proteins (ALB, SHBG, APOC2, APOC3, APOC4, SAA4) involved in lipid metabolism were selected and verified through PRM.
  • The identified proteins showed specific changes indicative of atherosclerosis.

Conclusions:

  • The study successfully identified six specific proteins related to lipid metabolism as potential diagnostic markers for atherosclerosis.
  • These protein biomarkers offer improved accuracy in diagnosing atherosclerosis, particularly in distinguishing between different disease presentations.
  • The findings contribute to the development of precise diagnostic tools for cardiovascular diseases, facilitating personalized treatment approaches.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
43
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
261
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
86
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
81
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
479
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
67